The Role of Podoplanin Inhibitors in Controlling Oral Cancer Progression

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer

(2023) Cynthia Rodríguez-Nava et al.   Biomedicines

Roles of Podoplanin in Malignant Progression of Tumor

(2022) Hiroyuki Suzuki et al.   Cells

Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia

(2022) Luís Monteiro et al.   Biomolecules

Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta‐analysis

(2022) Luis Monteiro et al.   ORAL DISEASES

Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies

(2021) Luigi Lorini et al.   Cancers

Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

(2021) Byeong-Oh Hwang et al.   Frontiers in Immunology

Oral potentially malignant disorders: A comprehensive review on clinical aspects and management

(2020) Saman Warnakulasuriya   ORAL ONCOLOGY

Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells

(2020) Nobuo Watanabe et al.   Cancer Cell International

Podoplanin as an Attractive Target of CAR T Cell Therapy

(2020) Masazumi Waseda et al.   Cells

Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways

(2020) Kelly L. Hamilton et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis

(2020) Silvio Abati et al.   International Journal of Environmental Research and Public Health

Podoplanin in Inflammation and Cancer

(2019) Miguel Quintanilla et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Structure-function and application of plant lectins in disease biology and immunity

(2019) Abtar Mishra et al.   FOOD AND CHEMICAL TOXICOLOGY

Podoplanin: An emerging cancer biomarker and therapeutic target

(2018) Harini Krishnan et al.   CANCER SCIENCE

Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target

(2018) Edward P. Retzbach et al.   ORAL ONCOLOGY

Oral potentially malignant disorders: risk of progression to malignancy

(2018) Paul M. Speight et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Podoplanin expression in oral leukoplakia─a prospective study

(2018) Kathrin J. Grochau et al.   JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY

C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice

(2017) T. Shirai et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

(2017) Sattva S. Neelapu et al.   Nature Reviews Clinical Oncology

Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

(2017) Juliane Gust et al.   Cancer Discovery

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

(2016) D. T. Teachey et al.   Cancer Discovery

CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains

(2016) S. Shiina et al.   Cancer Immunology Research

Lectins with Potential for Anti-Cancer Therapy

(2015) Tammy Yau et al.   MOLECULES

Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis

(2015) Yao-Wen Chang et al.   Oncotarget

Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms

(2015) Jhon A. Ochoa-Alvarez et al.   Oncotarget

Mechanistic explanation for platelet contribution to cancer metastasis

(2014) David Stegner et al.   THROMBOSIS RESEARCH

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin

(2014) Yukinari Kato et al.   Scientific Reports

Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development

(2012) Jin-Qiu Feng et al.   ORAL ONCOLOGY

Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration

(2012) Jhon Alberto Ochoa-Alvarez et al.   PLoS One

Podoplanin: emerging functions in development, the immune system, and cancer

(2012) Jillian L. Astarita et al.   Frontiers in Immunology

Enhanced Expression of Podoplanin in Oral Carcinomas in situ and Squamous Cell Carcinomas

(2011) Akinori Funayama et al.   PATHOBIOLOGY

Podoplanin expression during dysplasia–carcinoma sequence in the oral cavity

(2011) Harumi Inoue et al.   TUMOR BIOLOGY

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

(2010) L. Erpenbeck et al.   BLOOD

Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus

(2010) P. Shi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations

(2010) Matthias Kreppel et al.   VIRCHOWS ARCHIV

Characterization of Anti-podoplanin Monoclonal Antibodies: Critical Epitopes for Neutralizing the Interaction Between Podoplanin and CLEC-2

(2008) Satoshi Ogasawara et al.   HYBRIDOMA

Global epidemiology of oral and oropharyngeal cancer

(2008) Saman Warnakulasuriya   ORAL ONCOLOGY

A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus

(2007) Y.R. Li et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS